{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:15:12Z","timestamp":1788336912454,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Boehringer Ingelheim Animal Health USA, Inc","award":["201606030802"],"award-info":[{"award-number":["201606030802"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Domestic Animal Endocrinology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.domaniend.2020.106531","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T21:16:47Z","timestamp":1595971007000},"page":"106531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-0368","authenticated-orcid":false,"given":"A.B.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.T.","family":"Loynachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2987-5460","authenticated-orcid":false,"given":"V.D.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Campana-Emard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.T.","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.domaniend.2020.106531_bib1","series-title":"Recommendations for the diagnosis and treatment of pituitary pars intermedia dysfunction (PPID)","author":"Schott","year":"2017"},{"key":"10.1016\/j.domaniend.2020.106531_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cveq.2010.12.007","article-title":"Equine pituitary pars intermedia dysfunction","volume":"27","author":"McFarlane","year":"2011","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.domaniend.2020.106531_bib3","first-page":"293","article-title":"Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management","volume":"6","author":"Spelta","year":"2015","journal-title":"Vet Med (Auckl)"},{"key":"10.1016\/j.domaniend.2020.106531_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0749-0739(02)00018-4","article-title":"Pituitary pars intermedia dysfunction: equine Cushing's disease","volume":"18","author":"Schott","year":"2002","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.domaniend.2020.106531_bib5","series-title":"Recommendations for the diagnosis and treatment of pituitary pars intermedia dysfunction (PPID)","author":"Frank","year":"2015"},{"key":"10.1016\/j.domaniend.2020.106531_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jevs.2013.11.001","article-title":"Comparison of insulin and glucose metabolism in horses with pituitary pars intermedia dysfunction treated versus not treated with pergolide","volume":"34","author":"Gehlen","year":"2014","journal-title":"J Equine Vet Sci"},{"key":"10.1016\/j.domaniend.2020.106531_bib7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1939-1676.2010.0547.x","article-title":"Association of season and pasture grazing with blood hormone and metabolite concentrations in horses with presumed pituitary pars intermedia dysfunction","volume":"24","author":"Frank","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1939-1676.2005.tb02685.x","article-title":"Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses","volume":"19","author":"Donaldson","year":"2005","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1939-1676.2011.00810.x","article-title":"Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction","volume":"25","author":"Beech","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib10","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/en.2018-00726","article-title":"Dysregulation of cortisol metabolism in equine pituitary pars intermedia dysfunction","volume":"159","author":"Morgan","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2020.106531_bib11","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.2460\/ajvr.77.11.1236","article-title":"Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction","volume":"77","author":"Hart","year":"2016","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.domaniend.2020.106531_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/jvim.13839","article-title":"Effect of age, season, body condition, and endocrine status on serum free cortisol fraction and insulin concentration in horses","volume":"30","author":"Hart","year":"2016","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib13","first-page":"742","article-title":"Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease)","volume":"16","author":"Donaldson","year":"2002","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jvp.12339","article-title":"Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction","volume":"40","author":"McFarlane","year":"2017","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.domaniend.2020.106531_bib15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2746\/042516402776250333","article-title":"Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide","volume":"34","author":"Perkins","year":"2002","journal-title":"Equine Vet J"},{"key":"10.1016\/j.domaniend.2020.106531_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2746\/0425164044877288","article-title":"Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value","volume":"36","author":"McGowan","year":"2004","journal-title":"Equine Vet J"},{"key":"10.1016\/j.domaniend.2020.106531_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1939-1676.2011.0712.x","article-title":"Seasonal changes in plasma adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses","volume":"25","author":"Funk","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1939-1676.2011.0745.x","article-title":"The effect of geographic location, breed, and pituitary dysfunction on seasonal adrenocorticotropin and alpha-melanocyte-stimulating hormone plasma concentrations in horses","volume":"25","author":"McFarlane","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib19","series-title":"Equine respiratory diseases","author":"Rush","year":"2004"},{"key":"10.1016\/j.domaniend.2020.106531_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2746\/095777308X272120","article-title":"Rhodococcus equi pneumonia in an adult horse","volume":"20","author":"Waldridge","year":"2008","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.domaniend.2020.106531_bib21","first-page":"706","article-title":"Rhodococcus equi pleuropneumonia in an adult horse","volume":"43","author":"Vengust","year":"2002","journal-title":"Can Vet J"},{"key":"10.1016\/j.domaniend.2020.106531_bib22","series-title":"Equine internal medicine","author":"Reed","year":"2018"},{"key":"10.1016\/j.domaniend.2020.106531_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1939-1676.2010.0472.x","article-title":"Successful treatment of Rhodococcus equi pneumonia in an adult horse","volume":"24","author":"Morresey","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.2042-3306.2012.00578.x","article-title":"Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses","volume":"45","author":"McGowan","year":"2013","journal-title":"Equine Vet J"},{"key":"10.1016\/j.domaniend.2020.106531_bib25","series-title":"Abstract presented at: Equine Endocrinology Summit with the Dorothy Russell Havemeyer Foundation, Coral Gables, Florida","article-title":"Evaluating seasonal influences on hormone responses to a diagnostic test (thyrotropin-releasing hormone stimulation) advocated for early diagnosis of pituitary pars intermedia dysfunction (PPID)","author":"Adams","year":"2017"},{"key":"10.1016\/j.domaniend.2020.106531_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2460\/javma.231.3.417","article-title":"Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia","volume":"231","author":"Beech","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.domaniend.2020.106531_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jevs.2013.09.006","article-title":"Assessment of insulin and glucose dynamics by using an oral sugar test in horses","volume":"34","author":"Schuver","year":"2014","journal-title":"J Equine Vet Sci"},{"key":"10.1016\/j.domaniend.2020.106531_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1939-1676.2010.0667.x","article-title":"Serum free cortisol fraction in healthy and septic neonatal foals","volume":"25","author":"Hart","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.2042-3306.1983.tb01826.x","article-title":"Relationship between condition score, physical measurements and body fat percentage in mares","volume":"15","author":"Henneke","year":"1983","journal-title":"Equine Vet J"},{"key":"10.1016\/j.domaniend.2020.106531_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tvjl.2008.02.029","article-title":"Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies","volume":"179","author":"Carter","year":"2009","journal-title":"Vet J"},{"key":"10.1016\/j.domaniend.2020.106531_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-3164.2012.01080.x","article-title":"Comparison of hair follicle histology between horses with pituitary pars intermedia dysfunction and excessive hair growth and normal aged horses","volume":"24","author":"Inner\u00e5","year":"2013","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.domaniend.2020.106531_bib32","first-page":"291","article-title":"Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction","volume":"70","author":"Art","year":"2006","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.domaniend.2020.106531_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/104063870501700502","article-title":"Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood","volume":"17","author":"Franck","year":"2005","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.domaniend.2020.106531_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.mad.2008.09.004","article-title":"Advanced age in horses affects divisional history of T cells and inflammatory cytokine production","volume":"129","author":"Adams","year":"2008","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.domaniend.2020.106531_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.vetimm.2008.10.323","article-title":"Effect of body condition, body weight and adiposity on inflammatory cytokine responses in old horses","volume":"127","author":"Adams","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.domaniend.2020.106531_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.vetimm.2006.02.010","article-title":"Foals are interferon gamma-deficient at birth","volume":"112","author":"Breathnach","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.domaniend.2020.106531_bib37","series-title":"Theses and Dissertations--Veterinary Science","article-title":"Lymphocyte-Mediated Inflamm-Aging in the Horse","volume":"32","author":"Siard","year":"2017"},{"key":"10.1016\/j.domaniend.2020.106531_bib38","doi-asserted-by":"crossref","first-page":"110634","DOI":"10.1016\/j.exger.2019.110634","article-title":"Age-related dynamics of pro-inflammatory cytokines in equine bronchoalveolar lavage (BAL) fluid and peripheral blood from horses managed on pasture","volume":"124","author":"Hansen","year":"2019","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.domaniend.2020.106531_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.domaniend.2020.106531_bib40","article-title":"Duncan & Prasse\u2019s Veterinary Laboratory Medicine: Clinical Pathology","author":"Latimer","year":"2011"},{"key":"10.1016\/j.domaniend.2020.106531_bib41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1939-1676.2008.0076.x","article-title":"Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction","volume":"22","author":"McFarlane","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cveq.2016.04.009","article-title":"Immune dysfunction in aged horses","volume":"32","author":"McFarlane","year":"2016","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.domaniend.2020.106531_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vetimm.2015.04.006","article-title":"Neutrophil function in healthy aged horses and horses with pituitary dysfunction","volume":"165","author":"McFarlane","year":"2015","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.domaniend.2020.106531_bib44","first-page":"664","article-title":"Bioactivity of plasma ACTH from horses with PPID compared to normal horses","volume":"25","author":"Cordero","year":"2011","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.domaniend.2020.106531_bib45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/endo-111-2-559","article-title":"Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease","volume":"111","author":"Orth","year":"1982","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2020.106531_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.braindev.2008.11.007","article-title":"A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome","volume":"31","author":"Ohya","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.domaniend.2020.106531_bib47","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10571-005-3972-8","article-title":"ACTH enhancement of T-lymphocyte cytotoxic responses","volume":"25","author":"Johnson","year":"2005","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.domaniend.2020.106531_bib48","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/1381612805666230111194256","article-title":"ACTH and its role in immune-neuroendocrine functions. A comparative study","volume":"5","author":"Ottaviani","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.domaniend.2020.106531_bib49","doi-asserted-by":"crossref","first-page":"e71902","DOI":"10.1371\/journal.pone.0071902","article-title":"ACTH- and cortisol-associated neutrophil modulation in coronary artery disease patients undergoing stent implantation","volume":"8","author":"Keresztes","year":"2013","journal-title":"PLoS One"}],"container-title":["Domestic Animal Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724020300989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724020300989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:57:23Z","timestamp":1760036243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0739724020300989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":49,"alternative-id":["S0739724020300989"],"URL":"https:\/\/doi.org\/10.1016\/j.domaniend.2020.106531","relation":{},"ISSN":["0739-7240"],"issn-type":[{"value":"0739-7240","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses","name":"articletitle","label":"Article Title"},{"value":"Domestic Animal Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.domaniend.2020.106531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106531"}}